[1]
|
Ginsberg, F. and Parrillo, J.E. (2013) Fulminant Myocarditis. Critical Care Clinics, 29, 465-483.
https://doi.org/10.1016/j.ccc.2013.03.004
|
[2]
|
杜军保, 张清友. 暴发性心肌炎的诊断与紧急救治[J]. 实用儿科临床杂志, 2004, 19(11): 925-927.
|
[3]
|
Hiroyuki, M., et al. (2016) Clinical Features of Acute and Fulminant Myo-carditis in Children—2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circula-tion Journal, 80, 2362-2368.
https://doi.org/10.1253/circj.CJ-16-0234
|
[4]
|
易聪, 佘香, 易岂建. 222例儿童病毒性心肌炎临床分析[J]. 重庆医科大学学报, 2020,45(4): 459-463.
|
[5]
|
夏源园, 龚方戚. 50例儿童暴发性心肌炎的临床特点及危险因素分析[C]//2018年浙江省医学会儿科学分会学术年会. 2018: 330-331.
|
[6]
|
汤磊, 朱叶芳. 36例儿童暴发性心肌炎的临床分析[J]. 重庆医学, 2014, 43(31): 4241-4242.
|
[7]
|
Sankar, J., Khalil, S., Jeeva, S.M., et al. (2011) Short-Term Outcomes of Acute Fulminant Myocarditis in Children. Pediatric Cardiology, 32, 885-890. https://doi.org/10.1007/s00246-011-0007-8
|
[8]
|
McCarthy, R.R., Boehmer, J.P., Hruban, R.H., et al. (2000) Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) Myocarditis. The New England Journal of Medicine, 342, 690-695.
https://doi.org/10.1056/NEJM200003093421003
|
[9]
|
Amabile, N., Fraisse, A., Bouvenot, J., et al. (2006) Out-come of Acute Fulminant Myocarditis in Children. Heart, 92, 1269-1273. https://doi.org/10.1136/hrt.2005.078402
|
[10]
|
成人暴发性心肌炎诊断与治疗中国专家共识[J]. 中华心血管病杂志, 2017, 45(9): 742-752.
|
[11]
|
Feldman, A.M. and McNamara, D. (2000) Myocarditis. The New England Journal of Medicine, 343, 1388-1398.
https://doi.org/10.1056/NEJM200011093431908
|
[12]
|
Cooper, L.J. (2009) Myocarditis. The New England Journal of Medicine, 360, 1526-1538.
https://doi.org/10.1056/NEJMra0800028
|
[13]
|
Maisch, B., Ruppert, V. and Pankuweit, S. (2014) Management of Fulminant Myocarditis: A Diagnosis in Search of Its Etiology but with Therapeutic Options. Current Heart Failure Re-ports, 11, 166-177.
https://doi.org/10.1007/s11897-014-0196-6
|
[14]
|
Barton, M., Finkelstein, Y., Opavsky, M.A., et al. (2008) Eosin-ophilic Myocarditis Temporally Associated with Conjugate Meningococcal C and Hepatitis B Vaccines in Children. The Pediatric Infectious Disease Journal, 27, 831-835.
https://doi.org/10.1097/INF.0b013e31816ff7b2
|
[15]
|
Enko, K., Tada, T., Ohgo, K.O., et al. (2009) Fulminant Eo-sinophilic Myocarditis Associated with Visceral Larva Migrans Caused by Toxocara canis Infection. Circulation Journal, 73, 1344-1348.
https://doi.org/10.1253/circj.CJ-08-0334
|
[16]
|
Izumi, T., Kodama, M. and Shibata, A. (1991) Experimental Giant Cell Myocarditis Induced by Cardiac Myosin Immunization. European Heart Journal, 12, 166-168. https://doi.org/10.1093/eurheartj/12.suppl_D.166
|
[17]
|
Swirski, F.K. and Nahrendorf, M. (2018) Cardioimmunolo-gy: The Immune System in Cardiac Homeostasis and Disease. Nature Reviews Immunology, 18, 733-744. https://doi.org/10.1038/s41577-018-0065-8
|
[18]
|
Hulsmans, M., Clauss, S., Xiao, L., et al. (2017) Macrophages Facilitate Electrical Conduction in the Heart. Cell, 169, 510-522. https://doi.org/10.1016/j.cell.2017.03.050
|
[19]
|
Pollack, A., Kontorovich, A.R., Fuster, V., et al. (2015) Viral My-ocarditis—Diagnosis, Treatment Options, and Current Controversies. Nature Reviews Cardiology, 12, 670-680. https://doi.org/10.1038/nrcardio.2015.108
|
[20]
|
Huber, S.A. and Lodge, P.A. (1984) Coxsackievirus B-3 Myocar-ditis in Balb/c Mice. Evidence for Autoimmunity to Myocyte Antigens. The American Journal of Pathology, 116, 21-29.
|
[21]
|
Rose, N.R., Wolfgram, L.J., Herskowitz, A., et al. (1986) Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3-Induced Myocarditis. Annals of the New York Academy of Sciences, 475, 146-156.
https://doi.org/10.1111/j.1749-6632.1986.tb20864.x
|
[22]
|
Kuhl, U., Pauschinger, M., Schwimmbeck, P.L., et al. (2003) Interferon-Beta Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients with Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction. Circulation, 107, 2793-2798. https://doi.org/10.1161/01.CIR.0000072766.67150.51
|
[23]
|
卢少玲, 张烁. 病毒性心肌炎演变为扩张型心肌病的机制[J]. 心血管康复医学杂志, 2016, 25(3): 341-343.
|
[24]
|
Liu, P.P. and Mason, J.W. (2001) Advances in the Un-derstanding of Myocarditis. Circulation, 104, 1076-1082.
https://doi.org/10.1161/hc3401.095198
|
[25]
|
Opavsky, M.A., Penninger, J., Aitken, K., et al. (1999) Susceptibility to Myocarditis Is Dependent on the Response of Alphabeta T Lymphocytes to Coxsackieviral Infection. Circulation Re-search, 85, 551-558.
https://doi.org/10.1161/01.RES.85.6.551
|
[26]
|
Jensen, L.D. and Marchant, D.J. (2016) Emerging Pharmacologic Targets and Treatments for Myocarditis. Pharmacology & Therapeutics, 161, 40-51. https://doi.org/10.1016/j.pharmthera.2016.03.006
|
[27]
|
Bozkurt, B., Colvin, M., Cook, J., et al. (2016) Current Di-agnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement from the American Heart Association. Circulation, 134, e579-e646.
https://doi.org/10.1161/CIR.0000000000000455
|
[28]
|
Li, S., Xu, S., Li, C., et al. (2019) A Life Support-Based Comprehensive Treatment Regimen Dramatically Lowers the In-Hospital Mortality of Patients with Fulminant Myocardi-tis: A Multiple Center Study. Science China Life Sciences, 62, 369-380. https://doi.org/10.1007/s11427-018-9501-9
|
[29]
|
Blagova, O., Nedostup, A., Kogan, E., et al. (2020) Immunosup-pressive Therapy of Biopsy Proved Immune-Mediated Lymphocytic Myocarditis in the Virus-Negative and Vi-rus-Positive Patients. Cardiovascular Pathology, 49, Article ID: 107260. https://doi.org/10.1016/j.carpath.2020.107260
|
[30]
|
Allen, S.F., Godley, R.W., Evron, J.M., et al. (2014) Acute Necrotizing Eosinophilic Myocarditis in a Patient Taking Garcinia cambogia Extract Successfully Treated with High-Dose Corticosteroids. The Canadian Journal of Cardiology, 30, 1713-1732. https://doi.org/10.1016/j.cjca.2014.08.025
|
[31]
|
Callan, P.D., Baltabaeva, A., Kamal, M., et al. (2017) Acute Fulmi-nant Necrotizing Eosinophilic Myocarditis: Early Diagnosis and Treatment. ESC Heart Failure, 4, 660-664. https://doi.org/10.1002/ehf2.12146
|
[32]
|
Yonenaga, A., Hasumi, E., Fujiu, K., et al. (2018) Prognostic Improve-ment of Acute Necrotizing Eosinophilic Myocarditis (ANEM) through a Rapid Pathological Diagnosis and Appropriate Therapy. International Heart Journal, 59, 641-646. https://doi.org/10.1536/ihj.17-308
|
[33]
|
Ekstrom, K., Lehtonen, J., Kandolin, R., et al. (2016) Long-Term Outcome and Its Predictors in Giant Cell Myocarditis. European Journal of Heart Failure, 18, 1452-1458. https://doi.org/10.1002/ejhf.606
|
[34]
|
Bjelakovic, B., Vukomanovic, V. and Jovic, M. (2016) Fulminant Myocarditis in Children Successfully Treated with High Dose of Methyl-Prednisolone. Indian Journal of Pediatrics, 83, 268-269.
https://doi.org/10.1007/s12098-015-1831-2
|
[35]
|
李骄. 儿童暴发性心肌炎67例临床分析[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2016.
|
[36]
|
Esmel-Vilomara, R., Dolader, P., Izquierdo-Blasco, J., et al. (2022) Parvovirus B19 Myocarditis in Children: A Diagnostic and Therapeutic Approach. European Journal of Pediatrics, 181, 2045-2053.
https://doi.org/10.1007/s00431-022-04406-x
|
[37]
|
Maisch, B. and Pankuweit, S. (2012) Current Treatment Options in (Peri)myocarditis and Inflammatory Cardiomyopathy. Herz, 37, 644-656. https://doi.org/10.1007/s00059-012-3679-9
|
[38]
|
Anthony, R.M., Nimmerjahn, F., Ashline, D.J., et al. (2008) Re-capitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc. Science, 320, 373-376. https://doi.org/10.1126/science.1154315
|
[39]
|
Shioji, K., Kishimoto, C. and Sasayama, S. (2001) Fc Recep-tor-Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis: Concomitant Sup-pression of the Expression of Dendritic Cells. Circulation Research, 89, 540-546. https://doi.org/10.1161/hh1801.096263
|
[40]
|
Drucker, N.A., Colan, S.D., Lewis, A.B., et al. (1994) Gam-ma-Globulin Treatment of Acute Myocarditis in the Pediatric Population. Circulation, 89, 252-257. https://doi.org/10.1161/01.CIR.89.1.252
|
[41]
|
杨晓霞, 李忠义. 大剂量丙种球蛋白及甲基泼尼松龙冲击治疗小儿暴发性心肌炎32例临床分析[J]. 临床医药实践, 2011, 20(3): 197-198.
|
[42]
|
Piccininni, J.A., Richmond, M.E., Cheung, E.W., et al. (2018) Influenza Myocarditis Treated with Antithymocyte Globulin. Pediatrics, 142, e20180884. https://doi.org/10.1542/peds.2018-0884
|
[43]
|
Barry, T., Gallen, R., Freeman, C., et al. (2021) Successful Treatment of Steroid-Refractory Checkpoint Inhibitor Myocarditis with Globulin Derived-Therapy: A Case Report and Literature Review. The American Journal of the Medical Sciences, 362, 424-432. https://doi.org/10.1016/j.amjms.2021.04.018
|
[44]
|
Huang, X., Sun, Y., Su, G., et al. (2019) Intravenous Immuno-globulin Therapy for Acute Myocarditis in Children and Adults. International Heart Journal, 60, 359-365. https://doi.org/10.1536/ihj.18-299
|
[45]
|
Isogai, T., Yasunaga, H., Matsui, H., et al. (2015) Effect of Intravenous Immunoglobulin for Fulminant Myocarditis on In-Hospital Mortality: Propensity Score Analyses. Journal of Cardiac Failure, 21, 391-397.
https://doi.org/10.1016/j.cardfail.2015.01.004
|
[46]
|
Takada, H., Kishimoto, C. and Hiraoka, Y. (1995) Therapy with Immunoglobulin Suppresses Myocarditis in a Murine Coxsackievirus B3 Model. Antiviral and Anti-Inflammatory Ef-fects. Circulation, 92, 1604-1611.
https://doi.org/10.1161/01.CIR.92.6.1604
|
[47]
|
Hafezi-Moghadam, A., Simoncini, T., Yang, Z., et al. (2002) Acute Cardiovascular Protective Effects of Corticosteroids Are Mediated by Non-Transcriptional Activation of Endothelial Ni-tric Oxide Synthase. Nature Medicine, 8, 473-479.
https://doi.org/10.1038/nm0502-473
|
[48]
|
Cooper, L.J., Berry, G.J. and Shabetai, R. (1997) Idiopathic Giant-Cell Myocarditis—Natural History and Treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. The New England Journal of Medicine, 336, 1860-1866.
https://doi.org/10.1056/NEJM199706263362603
|
[49]
|
Cooper, L.T. (2007) Giant Cell Myocarditis in Children. Progress in Pediatric Cardiology, 24, 47-49.
https://doi.org/10.1016/j.ppedcard.2007.08.002
|
[50]
|
Marcolongo, R., Rizzo, S., Cerutti, A., et al. (2021) The Mul-tiple Faces of Autoimmune/Immune-Mediated Myocarditis in Children: A Biopsy-Proven Case Series Treated with Im-munosuppressive Therapy. ESC Heart Failure, 8, 1604- 1609. https://doi.org/10.1002/ehf2.13163
|
[51]
|
Steinhaus, D., Gelfand, E., VanderLaan, P.A., et al. (2014) Recovery of Giant-Cell Myocarditis Using Combined Cytolytic Immu-nosuppression and Mechanical Circulatory Support. The Journal of Heart and Lung Transplantation, 33, 769-771. https://doi.org/10.1016/j.healun.2014.02.018
|
[52]
|
Chaudhry, M.A., Correa, A., Lee, C., et al. (2015) Modern Day Management of Giant Cell Myocarditis. International Journal of Cardiology, 178, 82-84. https://doi.org/10.1016/j.ijcard.2014.10.131
|
[53]
|
Grabmaier, U., Brenner, C., Methe, H., et al. (2013) An Alterna-tive Immunosuppressive Regimen to Prolong Transplant Free Survival in a Patient with Giant Cell Myocarditis. Interna-tional Journal of Cardiology, 168, e27-e28.
https://doi.org/10.1016/j.ijcard.2013.05.078
|
[54]
|
Hang, W., Chen, C., Seubert, J.M., et al. (2020) Fulminant Myo-carditis: A Comprehensive Review from Etiology to Treatments and Outcomes. Signal Transduction and Targeted Therapy, 5, 287.
https://doi.org/10.1038/s41392-020-00360-y
|
[55]
|
Kraft, L., Erdenesukh, T., Sauter, M., et al. (2019) Blocking the IL-1beta Signalling Pathway Prevents Chronic Viral Myocarditis and Cardiac Remodeling. Basic Research in Cardiology, 114, 11.
https://doi.org/10.1007/s00395-019-0719-0
|